Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trials.

Publication Year: 2023

DOI:
10.1038/s41416-023-02217-x

PMCID:
PMC10206103

PMID:
36966233

Journal Information

Full Title: Br J Cancer

Abbreviation: Br J Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests DC: Research funding from MedImmune, AstraZeneca, Clovis, Eli Lily, 4SC, Bayer, Celgene, NIHR EME, and Roche; Scientific advisory board for OVIBIO. IC: Research funding from Eli-Lilly, Janssen-Cilag; Honorarium from Eli-Lilly, Eisai, Servier; Advisory board for Eli-Lilly, Bristol Meyers Squibb, MSD, Roche, Merck-Serono, AstraZeneca, OncXerna, Pierre Fabre, Boehringer Ingelheim, Incyte, Astella, GSK, Sotio, Eisai, Daiichi-Sankyo, Taiho, Servier. Naureen Starling: Research funding from Merck, AstraZeneca, BMS, Pfizer; honoraria from Merck-Serono, Novartis, MSD Oncology, Eli Lily, Pierre Fabre, Amgen, GSK, Servier; Advisory board for Pfizer, Servier, AstraZeneca, MSD Oncology, Novartis; travel funding from AstraZeneca, BMS, Eli Lily, Merck, Roche, MSD Oncology. HIG: Advisory board for AstraZeneca and BMS. The remaining authors declare no competing interests."

Evidence found in paper:

"Funding This work represents independent research supported by the National Institute for Health and Care Research (NIHR) Biomedical Research Centre at The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London. We would also like to acknowledge CRUK funding for tissue collection and slide scanning."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025